Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality
NCT ID: NCT01632839
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
298 participants
OBSERVATIONAL
2013-01-18
2017-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a French Version of the PISQ-R
NCT01548976
Validation of a New Sexuality Questionnaire for Patients With Urinary Incontinence or Pelvic Organ Prolapse
NCT01548989
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
NCT05527665
Validation of the Short Form of the "Lower Urinary Tract Symptoms Treatment Constraints Assessment" Questionnaire
NCT06853366
Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function
NCT03591393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaginal surgery +prothesis +sexuality
The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are sexually active.
No interventions assigned to this group
Vaginal surgery +prothesis -sexuality
The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are NOT sexually active.
No interventions assigned to this group
Vaginal surgery -prothesis + sexuality
The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are sexually active.
No interventions assigned to this group
Vaginal surgery -prothesis -sexuality
The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are NOT sexually active.
No interventions assigned to this group
Abdominal surgery +sexuality
The 50 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are sexually active.
No interventions assigned to this group
Abdominal surgery -sexuality
The 25 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are NOT sexually active.
No interventions assigned to this group
Urinary incontinence surgery + sexuality
The 50 patients included in this group will have surgery for urinary incontinence; these patients are sexually active.
No interventions assigned to this group
Urinary incontinence surgery - sexuality
The 25 patients included in this group will have surgery for urinary incontinence; these patients are NOT sexually active.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient can read and understand French
* The patient must have given her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient has genital prolapse and/or urinary incontinence and/or anal incontinence, and have undergone surgery
Exclusion Criteria
* The patient does not understand french
* Patient has vulvodynia
* Patient has painful bladder syndrome
* The patient has had chronic pelvic pain for longer than 6 months
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renaud de Tayrac, MD PhD
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nîmes
Brigitte Fatton, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
APHP - Hôpital Antoine Beclere
Clamart, , France
CHU de Clermont Ferrand - Hôpital Estaing
Clermont-Ferrand, , France
G.C.S. Flandre Maritime - site Polyclinique de Grande-Synthe
Grande-Synthe, , France
CH de la Rochelle
La Rochelle, , France
APHP - Centre Hospitalier Universitaire de Bicêtre
Le Kremlin-Bicêtre, , France
CHRU de Lille - Hôpital Jeanne de Flandre
Lille, , France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Groupe Hospitalier Dioconesses - Site Reuilly
Paris, , France
APHP - Hôpital Bichat - Claude Bernard
Paris, , France
CHU de Poitiers
Poitiers, , France
CH de la Région d'Annecy
Pringy, , France
CH de Poissy - Saint-Germain-en-Laye
Saint-Germain-en-Laye, , France
CHRU de Strasbourg - Hôpital de Hautepierre
Strasbourg, , France
Hôpital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fatton B, Hermieu JF, Lucot JP, Debodinance P, Cour F, Alonso S, de Tayrac R. French validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2021 Dec;32(12):3183-3198. doi: 10.1007/s00192-020-04625-6. Epub 2021 Jan 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00303-40
Identifier Type: OTHER
Identifier Source: secondary_id
LOCAL/2011/BF-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.